WFDC2 and ovarian carcinoma: HE4 has been studied extensively, especially for ovarian cancer, for which HE4 displays a tumor located, up-regulated, and secreted into blood plasma, making it a potential serum biomarker for ovarian cancer and endometrial cancer [10, 16, 17].